Yes. Certain low-dose metformin products are authorised for supply as Pharmacy (P) medicines, which can be sold without a prescription but only under pharmacy supervision. These are intended for adults with mild to moderate type 2 diabetes who require basic glucose management. Prescription-only medicines (POM) are used for broader treatment regimens, higher doses or more complex cases.
The UK classification of human medicines divides products into Prescription Only Medicine (POM), Pharmacy medicine (P) and General Sales List (GSL) medicine. Pharmacy medicines may be supplied without a prescription, but retail sale and purchase are restricted to registered pharmacies. This ensures professional oversight, advice and safety checks even when patients order metformin online or purchase in person.
Metformin is an oral antidiabetic medicine belonging to the biguanide class. It helps lower blood glucose by reducing hepatic glucose production, improving insulin sensitivity and enhancing peripheral glucose uptake.
First synthesized in the 1920s, metformin’s glucose-lowering properties were recognized in the 1950s. It became a mainstay of treatment in type 2 diabetes from the 1990s due to its efficacy, safety profile and cardiovascular benefits.
The active pharmaceutical ingredient is metformin hydrochloride. UK products may include immediate-release tablets, modified-release (MR) tablets and combination packs with other antidiabetic agents.
Metformin has demonstrated reductions in cardiovascular events, favourable effects on weight stabilization, low risk of hypoglycaemia, and a long-standing evidence base from large clinical trials.
No. Metformin does not replace insulin but works by enhancing the body’s response to its own insulin and by reducing excessive sugar production in the liver.
No. Sulfonylureas stimulate insulin secretion from pancreatic beta cells, whereas metformin primarily reduces hepatic gluconeogenesis and improves peripheral insulin action.
No. SGLT2 inhibitors increase renal glucose excretion. Metformin’s mechanism is different and complements other classes in combination therapy.
Metformin lowers blood glucose through multiple pathways:
Immediate-release metformin is usually taken two or three times daily with meals to minimise gastrointestinal side effects. Modified-release tablets allow once-daily dosing and smoother plasma concentration profiles.
No, when used as monotherapy it has a low risk of causing low blood sugar. Hypoglycaemia is more likely when combined with insulin or insulin secretagogues.
Studies suggest benefits in reducing cardiovascular events, possible weight neutrality or modest weight loss, and potential favourable effects on lipid profiles.
Metformin’s full effect often develops over weeks to months, as metabolic adjustments and improvements in insulin sensitivity accumulate over time.
Prices vary by brand, formulation, pack size and retailer. Generic metformin is typically cheaper than branded equivalents. Orders placed online can benefit from bulk discounts, subscription savings and promotional offers.
Retail pricing strategies reflect wholesale costs, discount agreements, retailer overheads and coverage of pharmacy services. A lower price does not compromise quality if the product is UK-authorised and meets regulatory standards.
| Example | Strength | Formulation | Price | Status | Note |
|---|---|---|---|---|---|
| Generic Metformin A | 500 mg | Immediate-release tablets, 84 pack | £4.99 | In stock | Buy online for cheaper price per tablet |
| Generic Metformin MR | 1,000 mg | Modified-release tablets, 30 pack | £12.49 | In stock | Order fast delivery |
| Branded Metformin X | 500 mg | Immediate-release tablets, 56 pack | £18.00 | By prescription | Prescription-only product |
Metformin is available in a range of strengths: 500 mg, 850 mg and 1,000 mg immediate-release tablets, as well as 500 mg and 1,000 mg modified-release tablets. The legal status may vary with strength and formulation.
Immediate-release tablets dissolve quickly, requiring multiple daily doses. Modified-release tablets release metformin gradually, supporting once-daily dosing and potentially reducing gastrointestinal side effects.
Pack size determines supply duration, price per tablet and whether the product qualifies for pharmacy supply without prescription. Small packs (e.g., 14 or 28 tablets) are often pharmacy medicine (P), while larger packs usually require a prescription.
| Feature | Why it matters |
| Strength | Affects dose frequency and maximum daily intake |
| Formulation | Immediate or modified-release influences dosing schedule |
| Pack size | Defines legal classification and supply limits |
| Brand vs generic | Generic medicines offer cost savings with identical active ingredient |
Generic metformin contains the same active ingredient and must meet regulatory criteria for bioequivalence. Excipients, tablet appearance, packaging and price differ between manufacturers.
Type 2 diabetes is a metabolic disorder characterized by insulin resistance and relative insulin deficiency. It leads to chronic hyperglycaemia and associated microvascular and macrovascular complications if not managed effectively.
Metformin is first-line therapy for type 2 diabetes in overweight or obese adults, recommended by NICE guidelines. It can be used alone or in combination with other antidiabetic agents, including SGLT2 inhibitors, GLP-1 agonists and insulin.
Patients typically start with 500 mg once or twice daily with meals. Dose is gradually increased at monthly intervals to reduce gastrointestinal intolerance, reaching up to 2,000 mg daily in divided doses.
Glycated haemoglobin (HbA1c) is measured every 3–6 months to assess long-term control. Fasting plasma glucose and self-monitoring levels guide dose adjustments.
Metformin has favourable effects on weight stabilization, lipid profiles and cardiovascular risk reduction. It may also improve endothelial function and reduce the risk of certain cancers, though evidence is evolving.
Prescription Only Medicine supplies require a valid prescription from a qualified prescriber. Most metformin strengths above 500 mg and larger pack sizes are POM status.
Certain metformin presentations (e.g., 500 mg, 14-tablet pack) are classified as Pharmacy medicine. They can be supplied without prescription but only from a registered pharmacy with pharmacist oversight.
General Sales List medicines can be sold in general retail outlets. No metformin presentation in the UK currently qualifies as GSL due to safety and monitoring considerations.
Classification depends on strength, pack size, presentation and intended duration of self-care use. Lower strength small packs allow limited supply without prescription under pharmacy control.
The Medicines and Healthcare products Regulatory Agency (MHRA) decides on classification changes through safety and public health evaluations.
Combination therapy can address multiple pathophysiological defects, achieve better glycaemic control and reduce long-term complications.
Lifestyle modifications—diet, exercise, weight management and smoking cessation—are fundamental components of diabetes care alongside pharmacological treatments.
Both reduce blood glucose, but sulfonylureas carry a higher risk of hypoglycaemia and weight gain. Metformin is weight-neutral and has low hypoglycaemia risk.
SGLT2 inhibitors act by promoting urinary glucose excretion. They offer cardiovascular and renal benefits but have a higher cost compared to generic metformin.
| Feature | Metformin | Sulfonylurea | SGLT2 inhibitor |
| Main mechanism | Reduces hepatic glucose production | Stimulates insulin secretion | Increases urinary glucose excretion |
| Hypoglycaemia risk | Low | High | Low |
| Effect on weight | Neutral or modest loss | Weight gain | Modest loss |
| Cost | Cheap (generic) | Moderate | High (branded) |
No. Choice depends on patient characteristics, comorbidities, efficacy, tolerability, cost and guideline recommendations.
Yes. Carbohydrate quantity, quality and meal timing can greatly affect postprandial glucose. A balanced diet with low glycaemic index foods supports metformin therapy.
Excessive alcohol intake can cause hypoglycaemia, affect liver function and interact with diabetes medications. Moderate intake under guidance may be acceptable.
Smoking increases cardiovascular risk and may worsen insulin resistance. Smoking cessation is strongly advised for people with type 2 diabetes.
Regular physical activity improves insulin sensitivity, aids weight control and enhances cardiovascular health in combination with metformin.
Gastrointestinal symptoms such as nausea, diarrhoea, abdominal discomfort and flatulence can occur, especially at treatment initiation or dose escalation.
Starting metformin at a low dose, taking with food and using modified-release formulations can reduce the risk of GI intolerance.
| Area | Examples described in product information |
| Gastrointestinal | Nausea, vomiting, diarrhoea, abdominal pain |
| Vitamin B12 | Possible decrease in B12 absorption with long-term use |
| Hypersensitivity | Rare skin rash or allergic reaction |
| Lactic acidosis | Very rare but serious if risk factors present |
Long-term metformin use may reduce vitamin B12 absorption. Periodic monitoring and supplementation are recommended.
Comprehensive safety information ensures patients and healthcare professionals can recognize and manage adverse events promptly.
Metformin is renally excreted. Impaired renal function increases the risk of accumulation and lactic acidosis. eGFR should be assessed before starting and periodically thereafter.
Regular reviews assess glycaemic control, side effects, renal function, adherence and the need for dose adjustments or additional therapies.
Lactic acidosis is extremely rare but serious. Avoid metformin in patients with acute illness, severe dehydration, hypoxia or significant hepatic or cardiac impairment.
Metformin is often continued in gestational diabetes or pre-existing type 2 diabetes under specialist guidance. Safety data support use, but individual assessment is required.
Yes. Concomitant use with iodinated contrast media may increase lactic acidosis risk and often requires temporary discontinuation.
Renal impairment can cause metformin accumulation, so dose adjustment or discontinuation may be necessary based on eGFR.
Metformin should be paused before major surgery or procedures requiring intravenous contrast and resumed only after renal function has been verified.
Seriously dehydrated or hypoxic patients are at increased lactic acidosis risk and should stop metformin until stabilized.
A generic medicine contains the same active ingredient, strength and dosing as the reference branded product and meets regulatory standards for quality and efficacy.
Different manufacturers and presentations have distinct patient information leaflets describing specific excipients, legal classifications and pack sizes.
Pharmacist advice ensures correct use, dose titration, side effect management and safe supply of metformin, especially for online orders.
Reliable sources include the MHRA, electronic Medicines Compendium (eMC), NICE guidelines and qualified healthcare professionals at Markeaton Pharmacy, Derby.
No. This page provides general information. For personalised advice and safe supply of metformin, speak with the pharmacy team in-store or consult your healthcare provider.